•  
  •  
  •  
  •  

2025-10-01 19:47:11

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  AlokIndustries

Stock Report

  • Alok Industries Ltd consolidated Q1FY26 loss at Rs. 171.56 crores
  • Alok Industries Ltd posts consolidated loss of Rs. 74.47 crores in Q4FY25
  • Alok Industries Ltd Q2FY25 loss at Rs. 260.60 crores
  • Alok Industries Ltd reports consolidated loss of Rs. 206.87 crores in Q1 FY25
  • Alok Industries Ltd posts consolidated loss of Rs. 215.93 crores in Q4 FY2024
  • Alok Industries Ltd posts consolidated Q3FY24 loss of Rs. 229.92 crores
  • Reliance Industries Ltd invests Rs. 3300 crore in NCRPS of Alok Industries Ltd
  • Reliance Industries Ltd executes guarantee deed in favour of SBI for borrowings of Alok Industries Ltd
  • Alok Industries Ltd enters into facility agreements with SBI for term loan, working capital facility
  • Alok Industries Ltd consolidated Q1FY24 loss at Rs. 226.14 crores
  • Alok Industries Ltd Q4FY23 consolidated loss increases to Rs. 297.55 crores
  • ALOK Industries Ltd Q3FY23 consolidated loss at Rs. 249.83 crores
  • Alok Industries Ltd Q2FY23 consolidated loss increases to Rs. 191.50 crores
  • Alok Industries Ltd Q1 FY2022-23 consolidated loss at Rs. 141.58 crores
  • Alok Industries Q4FY22 consolidated loss at Rs. 26.76 crores
  • Mr. Nirav Parekh appointed as an Additional Director of ALOK Industries Limited
  • Alok Industries Ltd reduces loss in Q3FY22
  • Alok Industries Ltd Q2FY22 consolidated loss at Rs. 84.11 crore

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024